Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 17,940
+320 (1.82%)
Sep 1, 2026, 3:30 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 1.52 trillion as of September 1, 2026. Its market cap has decreased by -50.43% in one year.
Market Cap
1.52T
Enterprise Value
1.47T
Revenue
5.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,940.00
ChartMarket Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has decreased from 2.58T to 1.52T, a decrease of -40.87%. That is a compound annual growth rate of -5.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.52T | -76.99% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LigaChem Biosciences | 3.72T |
| Voronoi | 3.11T |
| SK bioscience | 3.06T |
| Hugel | 2.80T |
| D&D Pharmatech | 2.55T |
| OliX Pharmaceuticals | 2.23T |
| Orum Therapeutics | 1.43T |
| Chabiotech | 754.82B |